US scientists come on board

AUSTRALIAN Cancer Technology has appointed two US medical scientists to its scientific advisory board.

Rick Phipps and Professor Kerry O’Banion, both from the University of Rochester School of Medicine will join neuroscientist Professor David Felten and oncologist Professor Barry Body on the advisory board.

Professor Phipps, an immunologist and cancer researcher with interests in lung diseases and lymphomas is the director of the university’s lung biology and diseases program.

Professor O’Banion, associate professor of neurobiology and anatomy, is internationally known for his work on cyclooxgenase-2 and its critical role in neuroinflammation and neurodegenerative diseases. He is a co-holder of the patents for the use of COX-2 inhibitors.


Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer